Masters J R, Osborne E J, Walker M C, Parris C N
Institute of Urology and Nephrology, University College London, UK.
Int J Cancer. 1993 Jan 21;53(2):340-6. doi: 10.1002/ijc.2910530228.
Metastatic testis tumours, in contrast to most other types of cancer, can be cured by drugs. To investigate which classes of chemotherapeutic drug are differentially toxic to testis-tumour cells, we compared the in vitro dose-response curves of 5 human testis and 5 bladder-cancer cell lines to 12 compounds. The testis cells were hypersensitive to drugs that interact directly with DNA (m-amsa, bleomycin, cisplatin, doxorubicin, methylnitrosourea, mitozolomide, etoposide, mitomycin-C), but little or no difference between the 2 cell types was seen following exposure to drugs whose mechanisms of action do not involve direct interaction with DNA (methotrexate, 5-fluorouracil, colchicine, vinblastine). We conclude that testis tumour cells are either less tolerant of, or have a reduced capacity to repair, DNA damage.
与大多数其他类型的癌症不同,转移性睾丸肿瘤可以通过药物治愈。为了研究哪类化疗药物对睾丸肿瘤细胞具有不同的毒性,我们比较了5种人睾丸癌细胞系和5种膀胱癌细胞系对12种化合物的体外剂量反应曲线。睾丸细胞对直接与DNA相互作用的药物(m-氨甲蝶呤、博来霉素、顺铂、阿霉素、甲基亚硝基脲、米托唑胺、依托泊苷、丝裂霉素-C)高度敏感,但在接触其作用机制不涉及与DNA直接相互作用的药物(甲氨蝶呤、5-氟尿嘧啶、秋水仙碱、长春碱)后,两种细胞类型之间几乎没有差异。我们得出结论,睾丸肿瘤细胞对DNA损伤的耐受性较低或修复能力降低。